AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18066631 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 444
Study 16420253 — intervention group
Group type: EXPERIMENTAL
Intervention: Trizivir (TZV) twice daily (n = 85)
Number of subjects: 254
Study 16420253 — intervention group
Group type: COMPARATOR
Intervention: Combivir/nelfinavir (COM/NFV) 1250 mg twice daily (n = 88)
Number of subjects: 254
Study 16420253 — intervention group
Group type: COMPARATOR
Intervention: Stavudine/lamivudine/nelfinavir (d4T/3TC/NFV) 40 mg+150 mg+1250 mg twice daily (n = 81)
Number of subjects: 254
Study 16420253 — intervention group
Group type: EXPERIMENTAL
Intervention: Trizivir (TZV)
Number of subjects: 254
Study 16420253 — intervention group
Group type: COMPARATOR
Intervention: Combivir/nelfinavir (COM/NFV) and Stavudine/lamivudine/nelfinavir (d4T/3TC/NFV)
Number of subjects: 254
Study 12562722 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg nightly for 7 days before IOS dose
Number of subjects: 15
Study 12562722 — intervention group
Group type: COMPARATOR
Intervention: Itraconazole oral solution (IOS) 400 mg
Number of subjects: 15
Study 11059872 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy for 12 months
Number of subjects: 0
Study 11059872 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy for 6 months
Number of subjects: 0
Study 11059872 — intervention group
Group type: COMPARATOR
Intervention: Interferon for 12 months
Number of subjects: 0
Study 9107581 — intervention group
Group type: EXPERIMENTAL
Intervention: Transmitted digital images
Number of subjects: 26
Study 9107581 — intervention group
Group type: COMPARATOR
Intervention: Plain radiographs (KUB)
Number of subjects: 26
Study 9107581 — intervention group
Group type: COMPARATOR
Intervention: Comparison of plain film and digital image interpretations
Number of subjects: 26
Study 8473720 — intervention group
Group type: EXPERIMENTAL
Intervention: moclobemide 200 mg
Number of subjects: 16
Study 8473720 — intervention group
Group type: EXPERIMENTAL
Intervention: moclobemide 400 mg
Number of subjects: 16
Study 8473720 — intervention group
Group type: COMPARATOR
Intervention: amitriptyline 50 mg
Number of subjects: 16
Study 8473720 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 16
Study 3513744 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0% suprofen
Number of subjects: 412
Study 3513744 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 412
Study 28814128 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth intervention (diabetes program)
Number of subjects: 126
Study 28814128 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 126
Study 27508319 — intervention group
Group type: EXPERIMENTAL
Intervention: fat-modified diet plus cholestyramine (8 g twice daily)
Number of subjects: 26
Study 27508319 — intervention group
Group type: COMPARATOR
Intervention: usual care
Number of subjects: 26
Study 24797765 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional educational material (SAGA tool)
Number of subjects: 773
Study 24797765 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 773
Study 24797765 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional educational material (SAGA tool) in treatment-naïve patients
Number of subjects: 773
Study 24797765 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment in treatment-naïve patients
Number of subjects: 773
Study 21685814 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrahospital combined circuit weight and aerobic training program
Number of subjects: 22
Study 21685814 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 22
Study 21036034 — intervention group
Group type: EXPERIMENTAL
Intervention: Biennial mammographic screening
Number of subjects: 1360
Study 18265446 — intervention group
Group type: EXPERIMENTAL
Intervention: New platelet products using platelet additive solutions
Number of subjects: 0
Study 18265446 — intervention group
Group type: COMPARATOR
Intervention: Standard platelet transfusion practices
Number of subjects: 0
Study 14759085 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin plus 100 mg/day ASA (group A, n = 70)
Number of subjects: 140
Study 14759085 — intervention group
Group type: COMPARATOR
Intervention: 100 mg/day ASA alone (group B, n = 70)
Number of subjects: 140
Study 11691649 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypo-energetic diet (6 weeks, week 0-6)
Number of subjects: 12
Study 11691649 — intervention group
Group type: EXPERIMENTAL
Intervention: Iso-energetic diet (4 weeks, week 6-10)
Number of subjects: 12
Study 11691649 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypo-energetic diet (6 weeks, week 10-16)
Number of subjects: 12
Study 9338539 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate powder (250 microg twice daily)
Number of subjects: 291
Study 9338539 — intervention group
Group type: COMPARATOR
Intervention: Triamcinolone acetonide aerosol (200 microg four times daily)
Number of subjects: 291
Study 9338539 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 291
Study 8081133 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous professional support
Number of subjects: 0
Study 8081133 — intervention group
Group type: COMPARATOR
Intervention: Early amniotomy
Number of subjects: 0
Study 8081133 — intervention group
Group type: COMPARATOR
Intervention: Early use of oxytocin
Number of subjects: 0
Study 8081133 — intervention group
Group type: COMPARATOR
Intervention: Combination of early amniotomy and early oxytocin
Number of subjects: 0
Study 8081133 — intervention group
Group type: COMPARATOR
Intervention: Strict diagnostic criteria for labour
Number of subjects: 0
Study 3652705 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency jet ventilation (HFJV) synchronized with the cardiac cycle (sync)
Number of subjects: 10
Study 3652705 — intervention group
Group type: COMPARATOR
Intervention: High-frequency jet ventilation (HFJV) nonsynchronized with the cardiac cycle (async)
Number of subjects: 10
Study 3652705 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency jet ventilation (HFJV) synchronized at sync 0
Number of subjects: 10
Study 3652705 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency jet ventilation (HFJV) synchronized at sync 60
Number of subjects: 10
Study 30953543 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous vitamin C (1.5 g), thiamine (100 mg), and hydrocortisone (50 mg) every 6 hours until 16 administrations or ICU discharge.
Number of subjects: 0
Study 30953543 — intervention group
Group type: COMPARATOR
Intervention: Matching placebos until a total of 16 administrations have been completed or ICU discharge occurs.
Number of subjects: 0
Study 30317013 — intervention group
Group type: EXPERIMENTAL
Intervention: High speed resistance training (HSRT)
Number of subjects: 28
Study 30317013 — intervention group
Group type: EXPERIMENTAL
Intervention: High speed resistance training plus balance exercises (HSRTB)
Number of subjects: 28
Study 30317013 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 28
Study 27829367 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 mg/kg IN ketamine
Number of subjects: 90
Study 27829367 — intervention group
Group type: COMPARATOR
Intervention: 0.1 mg/kg IV morphine
Number of subjects: 90
Study 27829367 — intervention group
Group type: COMPARATOR
Intervention: 0.15 mg/kg IM morphine
Number of subjects: 90
Study 24128184 — intervention group
Group type: EXPERIMENTAL
Intervention: Affective forecasting
Number of subjects: 6
Study 24128184 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention diversion from probability specifications
Number of subjects: 6
Study 24128184 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention drawn toward probability specifications
Number of subjects: 6
Study 24128184 — intervention group
Group type: EXPERIMENTAL
Intervention: More affectively intense forecasted outcome
Number of subjects: 6
Study 22314136 — intervention group
Group type: EXPERIMENTAL
Intervention: Measles vaccine at 4 months of age
Number of subjects: 0
Study 22314136 — intervention group
Group type: COMPARATOR
Intervention: Measles vaccine at 9 months of age (group 1)
Number of subjects: 0
Study 22314136 — intervention group
Group type: EXPERIMENTAL
Intervention: Booster at 36 months of age
Number of subjects: 0
Study 22314136 — intervention group
Group type: EXPERIMENTAL
Intervention: Re-vaccination
Number of subjects: 0
Study 22314136 — intervention group
Group type: EXPERIMENTAL
Intervention: At 48 months of age (group 2)
Number of subjects: 0
Study 19155117 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulator training with force feedback
Number of subjects: 101
Study 19155117 — intervention group
Group type: COMPARATOR
Intervention: Control group (no force feedback)
Number of subjects: 101
Study 17472324 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular training program (15 minutes duration, three balance exercises)
Number of subjects: 850
Study 17472324 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular training program (for compliers)
Number of subjects: 850
Study 17472324 — intervention group
Group type: COMPARATOR
Intervention: Control season
Number of subjects: 850
Study 17472324 — intervention group
Group type: EXPERIMENTAL
Intervention: Compliance with the program
Number of subjects: 850
Study 15940126 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation of 50 microg LPS
Number of subjects: 15
Study 15940126 — intervention group
Group type: COMPARATOR
Intervention: Oral methylprednisolone 20 mg/d for 6 days
Number of subjects: 15
Study 11752998 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal adenosine (2 mg)
Number of subjects: 65
Study 11752998 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal adenosine (0.25-2.0 mg)
Number of subjects: 65
Study 11752998 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 10912983 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol 400 microg
Number of subjects: 106
Study 10912983 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral misoprostol 400 microg
Number of subjects: 106
Study 10912983 — intervention group
Group type: EXPERIMENTAL
Intervention: Laminaria
Number of subjects: 106
Study 10912983 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 106
Study 7740420 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated sclerotherapy (n = 21)
Number of subjects: 45
Study 7740420 — intervention group
Group type: EXPERIMENTAL
Intervention: Interposition mesocaval shunt (n = 24)
Number of subjects: 45
Study 7740420 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 45
Study 2390255 — intervention group
Group type: COMPARATOR
Intervention: Thiopental sodium by infusion throughout CPB (n = 52)
Number of subjects: 100
Study 2390255 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopental sodium 15 mg/kg by bolus before aortic declamping (n = 48)
Number of subjects: 100
Study 6115596 — intervention group
Group type: COMPARATOR
Intervention: Morphine + Placebo
Number of subjects: 40
Study 6115596 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine + Cimetidine (H2)
Number of subjects: 40
Study 6115596 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine + Diphenhydramine (H1)
Number of subjects: 40
Study 6115596 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine + Cimetidine (H2) + Diphenhydramine (H1)
Number of subjects: 40
Study 31464063 — intervention group
Group type: EXPERIMENTAL
Intervention: Faster insulin aspart
Number of subjects: 15
Study 31464063 — intervention group
Group type: COMPARATOR
Intervention: Standard insulin aspart
Number of subjects: 15
Study 28216232 — intervention group
Group type: EXPERIMENTAL
Intervention: BIIB074 150 mg three times per day for 21 days, followed by random assignment to BIIB074 or placebo for up to 28 days.
Number of subjects: 67
Study 28216232 — intervention group
Group type: COMPARATOR
Intervention: Placebo for up to 28 days after open-label phase.
Number of subjects: 67
Study 28216232 — intervention group
Group type: EXPERIMENTAL
Intervention: BIIB074
Number of subjects: 67
Study 28216232 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study 25552403 — intervention group
Group type: EXPERIMENTAL
Intervention: 850 mg metformin hydrochloride administered p.o. in the evening of day 4 and in the morning of day 5
Number of subjects: 12
Study 25552403 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg trimethoprim administered p.o. twice daily for 5 days
Number of subjects: 12
Study 23967069 — intervention group
Group type: EXPERIMENTAL
Intervention: CyberSenga online healthy sexuality program (5-hour duration)
Number of subjects: 366
Study 23967069 — intervention group
Group type: EXPERIMENTAL
Intervention: CyberSenga with booster (4 months post-intervention)
Number of subjects: 366
Study 23967069 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (school-delivered sexuality programming)
Number of subjects: 366
Study 22104634 — intervention group
Group type: EXPERIMENTAL
Intervention: RLAI+TAU
Number of subjects: 45
Study 22104634 — intervention group
Group type: COMPARATOR
Intervention: TAU
Number of subjects: 45
Study 19930513 — intervention group
Group type: EXPERIMENTAL
Intervention: Erroneous examples with elaborated feedback
Number of subjects: 124
Study 19930513 — intervention group
Group type: COMPARATOR
Intervention: Erroneous examples with KCR feedback
Number of subjects: 124
Study 19930513 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditions with elaborated feedback
Number of subjects: 124
Study 17942872 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV test plus Pap test
Number of subjects: 12527
Study 17942872 — intervention group
Group type: COMPARATOR
Intervention: Pap test alone
Number of subjects: 12527
Study 15365225 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline (AMI)
Number of subjects: 80
Study 15365225 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine (PAROX)
Number of subjects: 80
Study 11493503 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 38
Study 11493503 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 38
Study 9830640 — intervention group
Group type: EXPERIMENTAL
Intervention: Maxillary and mandibular nerve blocks (n = 7)
Number of subjects: 14
Study 9830640 — intervention group
Group type: COMPARATOR
Intervention: Non-block group (without nerve blocks; n = 7)
Number of subjects: 14
Study 10155523 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive videodisc (IVD) instruction for 8 hours covering five subject areas: airway, head/cervical trauma, chest, shock, cardiac arrest.
Number of subjects: 150
Study 10155523 — intervention group
Group type: COMPARATOR
Intervention: Pre-IVD group (baseline)
Number of subjects: 150
Study 10155523 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-IVD group
Number of subjects: 150
Study 2241347 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephalothin
Number of subjects: 450
Study 2241347 — intervention group
Group type: COMPARATOR
Intervention: Cefamandole
Number of subjects: 450
Study 679592 — intervention group
Group type: EXPERIMENTAL
Intervention: Phase I drug testing program
Number of subjects: 29162
Study 679592 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29162
Study 30723321 — intervention group
Group type: EXPERIMENTAL
Intervention: Migalastat
Number of subjects: 14
Study 28068780 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone-assisted detoxification
Number of subjects: 150
Study 28068780 — intervention group
Group type: COMPARATOR
Intervention: Buprenorphine-assisted detoxification
Number of subjects: 150
Study 26780390 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyspeptic patients
Number of subjects: 106
Study 22427020 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (2 mg/kg)
Number of subjects: 99
Study 22427020 — intervention group
Group type: COMPARATOR
Intervention: Caffeine (1 mg/kg)
Number of subjects: 99
Study 22427020 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 21269041 — intervention group
Group type: EXPERIMENTAL
Intervention: Colgate Total Toothpaste (0.3% triclosan, 2.0% PVM/MA copolymer, 0.243% sodium fluoride)
Number of subjects: 109
Study 21269041 — intervention group
Group type: COMPARATOR
Intervention: Crest Pro-Health Toothpaste (0.454% stannous fluoride, sodium hexametaphosphate, zinc lactate)
Number of subjects: 109
Study 18427773 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 117
Study 18427773 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 117
Study 18427773 — intervention group
Group type: COMPARATOR
Intervention: Alendronate, vitamin D, and calcium (Control Group)
Number of subjects: 117
Study 15990753 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbonized MAC stent
Number of subjects: 396
Study 15990753 — intervention group
Group type: COMPARATOR
Intervention: High-grade stainless steel MAC stent
Number of subjects: 396
Study 14595299 — intervention group
Group type: EXPERIMENTAL
Intervention: Curved array echoendoscopy
Number of subjects: 104
Study 14595299 — intervention group
Group type: COMPARATOR
Intervention: Radial echoendoscopy
Number of subjects: 104
Study 10385127 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorzolamide
Number of subjects: 18
Study 10385127 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 8889673 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal heroin (6 mg)
Number of subjects: 6
Study 8889673 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal heroin (12 mg)
Number of subjects: 6
Study 8889673 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular heroin (6 mg)
Number of subjects: 6
Study 8889673 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection times for total morphine by GC‐MS and immunoassay (300‐ng/mL cutoff concentration)
Number of subjects: 6
Study 8889673 — intervention group
Group type: EXPERIMENTAL
Intervention: 6‐Acetylmorphine concentrations
Number of subjects: 6
Study 1988535 — intervention group
Group type: COMPARATOR
Intervention: PCA with morphine sulfate (MS) alone
Number of subjects: 30
Study 1988535 — intervention group
Group type: EXPERIMENTAL
Intervention: PCA plus continuous infusion of morphine sulfate (PCA + CI)
Number of subjects: 30
Study 6297417 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous suture technique
Number of subjects: 571
Study 6297417 — intervention group
Group type: COMPARATOR
Intervention: Interrupted suture technique
Number of subjects: 571
Study 30451329 — intervention group
Group type: EXPERIMENTAL
Intervention: Apremilast 30 mg twice daily
Number of subjects: 20
Study 30451329 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 29891957 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine replacement therapy and behaviour change counselling
Number of subjects: 800
Study 29891957 — intervention group
Group type: COMPARATOR
Intervention: Counselling alone
Number of subjects: 800
Study 26823037 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 0
Study 26823037 — intervention group
Group type: COMPARATOR
Intervention: Control group (basic therapies only)
Number of subjects: 0
Study 25190744 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Concurrent Training (HICT) consisting of two weekly sessions of speed endurance training (SET) followed by heavy resistance training (HRT) and two weekly sessions of aerobic training
Number of subjects: 23
Study 25190744 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Concurrent Training (HICT)
Number of subjects: 23
Study 25190744 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON) maintaining their training
Number of subjects: 23
Study 22355384 — intervention group
Group type: EXPERIMENTAL
Intervention: Helmet only
Number of subjects: 1557
Study 22355384 — intervention group
Group type: EXPERIMENTAL
Intervention: Helmet and information
Number of subjects: 1557
Study 22355384 — intervention group
Group type: EXPERIMENTAL
Intervention: Information only
Number of subjects: 1557
Study 22355384 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1557
Study 21174291 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative intra-aortic balloon pump (IABP) support
Number of subjects: 502
Study 21174291 — intervention group
Group type: COMPARATOR
Intervention: Control group with no preoperative IABP
Number of subjects: 502
Study 17537771 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic polysomnography night
Number of subjects: 20
Study 17537771 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP titration night
Number of subjects: 20
Study 17537771 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 20
Study 16765148 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nicotine
Number of subjects: 480
Study 16765148 — intervention group
Group type: COMPARATOR
Intervention: Nicotine nasal spray
Number of subjects: 480
Study 15255784 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium supplementation (960 micro g d(‐1), 3 months)
Number of subjects: 56
Study 15255784 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 10627331 — intervention group
Group type: EXPERIMENTAL
Intervention: Back propagation neural network
Number of subjects: 2
Study 10627331 — intervention group
Group type: COMPARATOR
Intervention: Statistical method
Number of subjects: 2
Study 9014483 — intervention group
Group type: EXPERIMENTAL
Intervention: Beni-koji aqueous extracts (27 g of beni-koji eq. per day) for 8 weeks
Number of subjects: 29
Study 9014483 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (apple juice)
Number of subjects: 29
Study 1551349 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide (40 mg/day)
Number of subjects: 20
Study 1551349 — intervention group
Group type: EXPERIMENTAL
Intervention: Domperidone (80 mg/day)
Number of subjects: 20
Study 1551349 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 3924720 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nutritional repletion with dextrose providing 0.95 times baseline resting energy expenditure
Number of subjects: 6
Study 3924720 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nutritional repletion with dextrose providing 1.75 times baseline resting energy expenditure
Number of subjects: 6
Study 3924720 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional repletion for 7 days
Number of subjects: 6